NewTimeSpace News: Yuanjie Semiconductor has received supplementary material requirements from regulators during the filing process for its proposed overseas offering and listing. The Company is required to clarify historical nominee shareholding arrangements and compliance of all prior equity transfers, ensure consistent maximum offering volume across filing documents and prospectus, verify compliance of employee equity incentive plans regarding external participants and share retention by departed grantees, and confirm continuous compliance with foreign investment access rules pre and post listing and full circulation. Legal counsel shall conduct relevant verification procedures and issue definitive legal opinions covering all above matters.
NewTimeSpace News: Enginetech Computer has received supplementary material requirements from regulators during the filing procedure for its proposed overseas offering and listing. The Company is required to elaborate on connected relationships among shareholders holding below 5% shares, reasonableness and legal procedures for capital reduction, compliance of equity incentive schemes, special shareholder rights arrangements, business qualifications and foreign investment negative list compliance, AI business identification, split of business operations between domestic and overseas subsidiaries, corporate governance implications arising from open-ended senior management tenures, and procedural compliance of extraordinary general meeting. Legal counsel is mandated to conduct comprehensive penetrating verification and issue clear legal opinions covering all above items.
newtimespace.com reports, Lygend Resources has submitted materials including the A-share prospectus registration draft to the Shenzhen Stock Exchange for its proposed A-share IPO, with the draft published on 10 July 2026. The company cautions that there is no guarantee the proposed issuance will be successfully completed as it remains subject to regulatory approvals.
NewTimeSpace News: XTX Technology Inc. refiled its listing application with the Hong Kong Stock Exchange on 10 July, with GF Securities and CITIC Securities acting as joint sponsors. According to China Insights Consultancy, measured by 2025 revenue, the Company ranks fifth globally among fabless suppliers of code flash memory chips, securing fourth place in SLC NAND Flash and fifth position in NOR Flash.
NewTimeSpace News: Ziyond Pharmaceutical Co., Ltd. filed a Main Board listing application with HKEX on 9 July, with CITIC Securities acting as the sole sponsor. According to Frost & Sullivan, the Company ranks first in China in terms of the total number of filed and approved topical dermatological medicines, and its commercialised products cover eight major dermatological indications in China.
NewTimeSpace News: Befar Group Co., Ltd (06745.HK) traded at HK$2.86 in grey market trading today, down HK$0.62 or 17.82% compared with the offer price of HK$3.48. The Company will be formally listed on the Main Board of HKEX on 10 July.
NewTimeSpace News: Grey market trading of Nexchip closed at HK$34, representing a gain of HK$1.7 or 5.26% versus the offer price of HK$32.3, with an intraday high of HK$37. The Company is scheduled for formal listing on the Main Board of HKEX on 10 July.
NewTimeSpace News: The listing application submitted by XTX Technology Inc. to HKEX on 9 January 2026 has lapsed upon expiry of the six-month validity window. GF Securities and CITIC Securities acted as the original joint sponsors. According to China Insights Consultancy (CIC), measured by 2024 revenue, the Company ranks sixth globally among fabless suppliers of code-type flash memory chips, fourth in the SLC NAND Flash segment and fifth in the NOR Flash segment.
NewTimeSpace News: The listing application submitted by Simcere Zaiming Pharmaceutical Co., Ltd. to HKEX on 9 January 2026 has lapsed following expiry of the six-month validity period. Morgan Stanley and CICC acted as the original joint sponsors. Focused on innovative oncology drug R&D, the Company completed three out-licensing transactions in 2025, ranking first by transaction count and fourth by aggregate deal value among Chinese biopharmaceutical companies. It struck landmark licensing partnerships with AbbVie, Ipsen and NextCure with a potential total consideration exceeding USD2.8 billion plus tiered royalties.
NewTimeSpace News: The listing application submitted by Jiwusiwei Limited to HKEX on 9 January 2026 has lapsed following the expiry of the six-month validity period. CICC and BOCI Global Securities acted as the original joint sponsors. Its flagship brand COMMUNE ranks as China’s top gastropub brand. According to Frost & Sullivan, measured by revenue, COMMUNE secured the No.1 position among domestic gastropub brands for three successive years from 2022 to 2024, capturing a market share of approximately 7.8% in 2024.
NewTimeSpace News: Ming Yu Pharmaceutical Limited re-submitted its listing application to HKEX on 8 July, with Morgan Stanley, BofA Securities and CITIC Securities acting as joint sponsors. Founded in 2018, it is an oncology-focused biotech company centred on integrative oncology, specialising in antibody-drug conjugates and advanced immunotherapies. Its pipeline comprises 11 independently discovered and developed candidates including two core assets.
NewTimeSpace News: Shenzhen POCO New Materials Co., Ltd. (300811.SZ) filed a listing application with HKEX on 8 July, with CITIC Securities acting as the sole sponsor. According to China Insights Consultancy (CIC), based on 2025 revenue, the Company ranks first in the global alloy soft magnetic powder core market with a market share of 27.1%, and fifth in the global AI chip inductor market with a market share of 7.6%. Its products have entered supply chains of world-leading AI chip enterprises and cloud service providers.
Dtech Technology has set its final IPO offer price at HK$380 per share, the upper end of the range, for a global offering of 12.632 million H shares. The Hong Kong public offering (excluding overseas employee preferential offering) was 354.64 times oversubscribed, while the international offering (excluding PRC employee preferential offering) was 24.50 times covered, raising net proceeds of approximately HK$4.665 billion. Cornerstone investors were allotted approximately 41.45% of the offer shares. Trading is expected to commence on 9 July 2026, with a board lot of 100 shares.
EKH Limited has decided not to proceed with its global offering and listing after consultation with overall coordinators, and the relevant underwriting agreements will not proceed. Although the Hong Kong public offering was oversubscribed, all application monies will be refunded in full without interest by 13 July 2026, and no share certificates will be issued to applicants.
Jiangxi Qiyunshan Food has set its final IPO offer price at HK$8.00 per share, the upper end of the range, for a global offering of 25 million H shares. The Hong Kong public offering was 1,688.1 times oversubscribed, while the international offering was 1.51 times covered, raising net proceeds of approximately HK$167 million. Controlling shareholders hold a combined 75% subject to lock-up until 8 July 2027. Trading is expected to commence on 9 July 2026, with a board lot of 500 shares.
RIGOL Technologies has fixed its global offering price at HK$45.98 per H share and expects to announce allotment results on 8 July 2026. If the global offering becomes unconditional before 8:00 a.m. on 9 July, H-share trading will commence at 9:00 a.m. on the same day, with a board lot of 100 shares.
